"The Heart & Vascular Institute is a recognized leader in heart disease diagnosis and treatment, including heart failure and transplant."

During the past decade, Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Ochsner Health System" with 1 trials as a collaborator, "University Hospitals Cleveland Medical Center" with 1 trials as a collaborator and "University of Arkansas" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center" are "Coronary Artery Disease" (2 trials), "Acute Type B Aortic Dissection (Uncomplicated)" (1 trials), "Aortic Dissection" (1 trials), "Blunt Thoracic Aortic Injury" (1 trials) and "Dissection, Aortic Acute" (1 trials). Many other conditions were trialed in "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center" in a lesser frequency.

Most popular intervention types in "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center" are "Device" (4 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Valiant Thoracic Stent Graft with the Captivia Delivery System" (2 trials), "BMT" (1 trials), "BMT+TEVAR" (1 trials), "Bupivacaine hydrochloride" (1 trials) and "Exparel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".